The physicians at Retina and Vitreous Associates have a long history of performing research studies on a local, regional, national and international level, often in collaboration with multiple other research centers, including the National Eye Institute. Below is a list of studies we are either performing right now, or have done in the past.
We are actively enrolling patients in the following studies:-
Study Name: AART (Anecortave Acetate Risk Reduction Trial)
Diagnosis Required: Dry and wet macular degeneration
Nature of Study: To determine if anecortave acetate (Retaane) can prevent dry macular degeneration from becoming wet macular degeneration in high risk patients
Enrollment Dates: Now until mid-August 2004
-
Study Name: Eyetech Macugen Trial for Occult CNV
Diagnosis Required: Occult choroidal neovascularization from wet macular degeneration
Nature of Study: Injection of study medicine every 6 weeks to determine if vision can be stabilized or improved
Enrollment Dates: 2003
Results Anticipated: Late 2004 or 2005 - Study Name: Anecortave Acetate Vs. Photodynamic Therapy for Predominately Classic CNV in Exudative AMD
Diagnosis Required: Wet Macular Degeneration, Predominately Classic
Nature of Study: Comparing a new injectable agent to photodynamic therapy for wet macular degeneration
Enrollment Dates: 2003
Results Anticipated: Late 2004 or 2005
We have completed these studies:
Study Name: Limited Macular Translocation Pilot Study
Year of Study: 1999
Study Name: Verteporfin in AMD
Year of Study: 1999
Study Name: Choroidal Neovascularization Prevention Trial
Year of Study: 1997
Study Name: The Submacular Surgery Trials
Year of Study: 1997
Study Name: The Takeda Study
Year of Study: 1997
Study Name: Kresge Perfluoron Study
Year of Study: 1994
Study Name: The Tolrestat Study
Year of Study: 1992
Study Name: Vitrectomy for Macular Hole Study
Year of Study: 1992
Study Name: Ocular Histoplasmosis Foveal Study
Year of Study: 1988
Study Name: The Silicone Oil Study
Year of Study: 1988